EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

Abstract

Catechins are key components of teas that have antiproliferative properties. We investigated the effects of green tea catechins on intracellular signalling and VEGF induction in vitro in serum-deprived HT29 human colon cancer cells and in vivo on the growth of HT29 cells in nude mice. In the in vitro studies, (-)-epigallocatechin gallate (EGCG), the most abundant catechin in green tea extract, inhibited Erk-1 and Erk-2 activation in a dose-dependent manner. However, other tea catechins such as (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epicatechin (EC) did not affect Erk-1 or 2 activation at a concentration of 30 microM. EGCG also inhibited the increase of VEGF expression and promoter activity induced by serum starvation. In the in vivo studies, athymic BALB/c nude mice were inoculated subcutaneously with HT29 cells and treated with daily intraperitoneal injections of EC (negative control) or EGCG at 1.5 mg day(-1)mouse(-1)starting 2 days after tumour cell inoculation. Treatment with EGCG inhibited tumour growth (58%), microvessel density (30%), and tumour cell proliferation (27%) and increased tumour cell apoptosis (1.9-fold) and endothelial cell apoptosis (3-fold) relative to the control condition (P< 0.05 for all comparisons). EGCG may exert at least part of its anticancer effect by inhibiting angiogenesis through blocking the induction of VEGF.

References 30

1. 1.

   Ahmad N., Feyes D. K., Nieminen A. L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst. 1997;89(24):1881-1886.

   Not in our library10.1093/jnci/89.24.1881

2. 2.

   Ahn H. Y., Hadizadeh K. R., Seul C., Yun Y. P., Vetter H., Sachinidis A. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell. 1999;10(4):1093-1104.

   Not in our library10.1091/mbc.10.4.1093

3. 3.

   Akagi Y., Liu W., Zebrowski B., Xie K., Ellis L. M. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. 1998;58(17):4008-4014.

   Not in our library

4. 4.

   Asano Y., Okamura S., Ogo T., Eto T., Otsuka T., Niho Y. Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia. Life Sci. 1997;60(2):135-142.

   Not in our library10.1016/s0024-3205(96)00603-0

5. 5.

   Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature. 1999;398(6726):381-381.

   Not in our library10.1038/18793

6. 6.

   Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J Biol Chem. 1995;270(25):14843-14846.

   Not in our library10.1074/jbc.270.25.14843

7. 7.

   Davis R. J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268(20):14553-14556.

   Not in our library

8. 8.

   Ellis L. M., Liu W., Wilson M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery. 1996;120(5):871-878.

   Not in our library10.1016/s0039-6060(96)80097-3

9. 9.

   Ellis L. M., Staley C. A., Liu W., Fleming R. Y., Parikh N. U., Bucana C. D., Gallick G. E. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J Biol Chem. 1998;273(2):1052-1057.

   Not in our library10.1074/jbc.273.2.1052

10. 10.

    Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27-31.

    Not in our library10.1038/nm0195-27

11. 11.

    Fujiki H., Suganuma M., Okabe S., Sueoka N., Komori A., Sueoka E., Kozu T., Tada Y., Suga K., Imai K. Cancer inhibition by green tea. Mutat Res. 1998;402(1-2):307-310.

    Not in our library10.1016/s0027-5107(97)00310-2

12. 12.

    Hibasami H., Komiya T., Achiwa Y., Ohnishi K., Kojima T., Nakanishi K., Akashi K., Hara Y. Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol Rep. 1998;5(2):527-529.

    Not in our library10.3892/or.5.2.527

13. 13.

    Jankun J., Selman S. H., Swiercz R., Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature. 1997;387(6633):561-561.

    Not in our library10.1038/42381

14. 14.

    Ji B. T., Chow W. H., Hsing A. W., McLaughlin J. K., Dai Q., Gao Y. T., Blot W. J., Fraumeni J. F. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer. 1997;70(3):255-258.

    Not in our library10.1002/(sici)1097-0215(19970127)70:3<255::aid-ijc1>3.0.co;2-w

15. 15.

    Jung Y. D., Nakano K., Liu W., Gallick G. E., Ellis L. M. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res. 1999;59(19):4804-4807.

    Not in our library

16. 16.

    Kitano K., Nam K. Y., Kimura S., Fujiki H., Imanishi Y. Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys Chem. 1997;65(2-3):157-164.

    Not in our library10.1016/s0301-4622(96)02254-5

17. 17.

    Liang Y. C., Lin-shiau S. Y., Chen C. F., Lin J. K. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 1997;67(1):55-65.

    Not in our library10.1002/(sici)1097-4644(19971001)67:1<55::aid-jcb6>3.0.co;2-v

18. 18.

    Mahadevan D., Thanki N., Aroca P., McPhie P., Yu J. C., Beeler J., Santos E., Wlodawer A., Heidaran M. A. A divalent metal ion binding site in the kinase insert domain of the alpha-platelet-derived growth factor receptor regulates its association with SH2 domains. Biochemistry. 1995;34(7):2095-2106.

    Not in our library10.1021/bi00007a002

19. 19.

    Milanini J., Viñals F., Pouysségur J., Pagès G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem. 1998;273(29):18165-18172.

    Not in our library10.1074/jbc.273.29.18165

20. 20.

    Paschka A. G., Butler R., Young C. Y. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 1998;130(1-2):1-7.

    Not in our library10.1016/s0304-3835(98)00084-6

21. 21.

    Rogers A. E., Hafer L. J., Iskander Y. S., Yang S. Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis. 1998;19(7):1269-1273.

    Not in our library10.1093/carcin/19.7.1269

22. 22.

    Sebolt-Leopold J. S., Dudley D. T., Herrera R., Van Becelaere K., Wiland A., Gowan R. C., Tecle H., Barrett S. D., Bridges A., Przybranowski S. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med. 1999;5(7):810-816.

    Not in our library10.1038/10533

23. 23.

    Stoner G. D., Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl. 1995;22:169-180.

    Not in our library10.1002/jcb.240590822

24. 24.

    Swiercz R., Skrzypczak-Jankun E., Merrell M. M., Selman S. H., Jankun J. Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator. Oncol Rep. 1999;6(3):523-526.

    Not in our library10.3892/or.6.3.523

25. 25.

    Takahashi Y., Bucana C. D., Liu W., Yoneda J., Kitadai Y., Cleary K. R., Ellis L. M. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst. 1996;88(16):1146-1151.

    Not in our library10.1093/jnci/88.16.1146

26. 26.

    Takahashi Y., Kitadai Y., Bucana C. D., Cleary K. R., Ellis L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55(18):3964-3968.

    Not in our library

27. 27.

    Takahashi Y., Tucker S. L., Kitadai Y., Koura A. N., Bucana C. D., Cleary K. R., Ellis L. M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997;132(5):541-546.

    Not in our library10.1001/archsurg.1997.01430290087018

28. 28.

    Warren R. S., Yuan H., Matli M. R., Gillett N. A., Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest. 1995;95(4):1789-1797.

    Not in our library10.1172/jci117857

29. 29.

    Yang C. S., Wang Z. Y. Tea and cancer. J Natl Cancer Inst. 1993;85(13):1038-1049.

    Not in our library10.1093/jnci/85.13.1038

30. 30.

    Yu G. P., Hsieh C. C., Wang L. Y., Yu S. Z., Li X. L., Jin T. H. Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control. 1995;6(6):532-538.

    Not in our library10.1007/bf00054162

Cited by papers we hold 5

• Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation · 2023
  No notice
• Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments · 2017
  No notice
• Broad targeting of angiogenesis for cancer prevention and therapy · 2015
  No notice
• EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression · 2013
  No notice
• Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate · 2007
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.